(Q21092899)

English

Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels

scientific article

Statements

Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels (English)
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit